CSC’s Grassroots Advocacy 101 Toolkit provides educational information on the different levels of advocacy, the legislative process, and how to tell your story and develop key messages. It also offers guidance on engaging with decision-makers in an impactful and respectful manner. The toolkit includes accessible examples of advocacy activities, such as meeting with legislators, making phone calls to offices of elected officials, writing advocacy letters, and using social media as a powerful advocacy tool to help you engage and advocate for the issues that matter most to you and your community. 

El camino a través de un diagnóstico de NMP es diferente para cada persona y no hay un mapa que funcione para todos. Independientemente de si es usted la persona que recibió un diagnóstico de NMP o un cuidador, esperamos que estos diez consejos que han aportado otras personas que viven con NMP lo ayuden en el camino.

This resource talks about the screening guidelines for different types of cancer. It describes screening procedures, self-examinations, and other prevention methods. It also talks about how to overcome barriers to screening.
 

If you have non-small cell lung cancer and your tumor tests positive for the KRAS biomarker, you have KRAS+ (KRAS positive) lung cancer. This fact sheet explains what this means and how it may affect lung cancer treatment.

If you have non-small cell lung cancer and your tumor tests positive for the RET biomarker, you have RET+ (RET positive) lung cancer. This fact sheet explains what this means and how it may affect lung cancer treatment. 

If you have non-small cell lung cancer and your tumor tests positive for the EGFR biomarker, you have EGFR+ (EGFR positive) lung cancer. This fact sheet explains what this means and how it may affect lung cancer treatment.

If you have non-small cell lung cancer and your tumor tests positive for the ALK biomarker, you have ALK+ (ALK positive) lung cancer. This fact sheet explains what this means and how it may affect lung cancer treatment.